Skip to main content

Nutex Health Inc 10-Q for FY2026 Q3

Nutex Health Inc. (NUTX)

10-Q 2026-11-05 For: 2026-09-30
View Original
Added on November 05, 2026

About this 10-Q

Nutex Health Inc filed this 10-Q on November 5, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Nutex Health’s arbitration costs totaled $27.8 million for the three months ended September 30, 2026 and $61.4 million for the nine months ended September 30, 2026, compared with $41.9 million and $116.2 million, respectively, in 2025. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$217.61M
down 18.7% from $267.8M a year earlier
Net income
$40.23M
down 27.4% from net income of $55.44M a year earlier
Diluted EPS
$5.71
down 26.4% from $7.76 a year earlier